BRCA2 Protein
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluation of Tomosynthesis for Characterization and the Management of Breast Lesions (NCT02959398) | Assistance Publique - Hôpitaux de Paris | 2017-11-20 |
| A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP) (NCT00516373) | AstraZeneca | 2005-07-11 |
Track BRCA2 Protein automatically
Every clearance here is in the API, with alerts when new ones post.